Study of MT027 for malignant pleural effusion
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have advanced solid tumor cancer that has spread to the lining of your lung (pleura) and caused fluid buildup (malignant pleural effusion) that needs to be drained.
- Your cancer has not responded to standard treatments, or you cannot have standard treatments.
- Your tumor or pleural fluid tests positive for a marker called B7-H3.
- You are in generally good health (able to care for yourself, out of bed more than half the day).
- Your blood counts, liver, kidney, and clotting function are within safe ranges.
- You agree to use reliable birth control for up to 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new therapy using your own immune cells (called TILs) to treat cancer that has spread to the lining of the lungs. The goal is to see if these cells can shrink tumors and help you feel better.
This trial tests a treatment using your own immune cells (T cells) to fight cancer that has spread to the lining of the lung and is causing fluid buildup. It may help if other standard treatments have stopped working.
This trial tests a new drug called MHB009C for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug called MHB042C for people with advanced solid tumors that have stopped responding to other treatments. It aims to see if the drug is safe and effective.
This study tests a new drug called MT027 for people whose solid tumors (like lung, breast, or colon cancer) have spread to the brain, the lining of the brain, or the spinal cord. It aims to see if the drug is safe and can help shrink or control these cancers.
This trial tests a new drug called JMKX000197 against a standard chemotherapy drug (cisplatin) to see which is better at reducing fluid buildup around the lungs in people with advanced cancer. The goal is to ease breathing and improve quality of life.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.